With the Life-on Chip event on the horizon, focused on ‘Exploring the Convergence in Health Technologies’, we want to look at what role Modis Life Sciences can play in this convergence. We reached out to our Modis Life Sciences Director of Project Solutions Alain Van Echelpoel & IT Director Sven Hofman to connect this convergence with our mission and vision proposal as well as our focus points in 2021.
Looking at the mission, vision and value proposition of Modis Life Sciences; can you recapitulate on the role of technology within the Life Sciences industry and Modis as service provider?
Our Modis Life Sciences mission and strategy is focused on a direct contribution, as a service provider and solution expert, to innovations in the domain of health and more precisely in the development and implementation of patient centric products, therapies, and services. Within the life sciences, we strive to be a trusted, knowledgeable and a preferred partner & advisor, supporting our clients and improving the quality for patients.
More and more, we see an evolution where digital solutions and technologies are entering research, development and therapeutic areas of life sciences and healthcare to bring holistic health solutions to market and patient. In addition, we are also seeing the convergence of life sciences, medtech and digital health industries. The digital solutions will play a key role in efficiency gains during the discovery, gathering and analyzing of data throughout the product lifecycle.
We want our customers to be prepared for the future by connecting our understanding of these new digital solutions with their challenges.
Looking at ‘the convergence in Healthcare Technologies’, what do you feel about the future of this convergence and how well is Belgium (EU) equipped to play a key role in these?
The convergence is currently happening and when specific hurdles are overcome, it will drive healthcare in the future. When used well, the convergence will support a more patient centric approach, where readily available data will be used to improve healthcare solutions throughout the product lifecycle from discovery to post-market.
Belgium is well fitted and offers a unique combination of tech innovators and a strong life sciences footprint. There is no denying that on such a small surface in the heart of Europe, we offer a unique mix: